Non-Alcoholic Fatty Liver Disease

List of Contributors, vii
 
1 What is non-alcoholic fatty liver disease (NAFLD), and why is it important? 1
Geoffrey C. Farrell, Arthur J. McCullough, and Christopher P. Day
 
2 NAFLD in the community, 17
Leon A. Adams
 

3 Pathology of NAFLD, 27
Elizabeth M. Brunt and David E. Kleiner
 
4 The natural history of NAFLD, 37
Paul Angulo
 
5 Emerging concepts on the pathogenesis of non-alcoholic steatohepatitis (NASH), 46
Isabelle A. Leclercq
 
6 Diabetes and NAFLD: why is the connection important? 62
Elisabetta Bugianesi
 
7 NAFLD and cardiovascular risk factors: implications for vascular disease, 71
Giovanni Targher
 
8 A primary care perspective of fatty liver: diagnosis, management, prescribing, and when to refer, 84
Shivakumar Chitturi and Geoffrey C. Farrell
 
9 Imaging of NAFLD, 93
Takeshi Yokoo, An Tang, and Claude B. Sirlin
 
10 Non-invasive methods to determine the severity of NAFLD and NASH, 112
Vincent Wai-Sun Wong and Henry Lik-Yuen Chan
 
11 Fatigue, quality of life, and psychosocial issues for people with NAFLD, 122
Julia L. Newton and James Frith
 
12 Physical activity and cardiovascular fi tness in patients with NAFLD: clinical importance and therapeutic implications, 132
Ingrid J. Hickman, Graeme A. Macdonald, and Nuala M. Byrne
 
13 NAFLD, obesity, and bariatric surgery, 149
Philippe Mathurin
 
14 Genetic predisposition to NAFLD and NASH: implications for pathogenesis, diagnosis, prevention, and management, 157
Quentin M. Anstee, Ann K. Daly, and Christopher P. Day
 
15 NAFLD in children, 171
Ariel E. Feldstein
 
16 The pointy end of the NAFLD iceberg: cirrhosis, portal hypertension, and liver failure, 182
Jonathon W. Schwake, Dawn M. Torres, and Stephen A. Harrison
 
17 Non-alcoholic fatty liver disease, hepatocellular cancer, and other cancers, 192
Janine Graham and Helen L. Reeves
 
18 NAFLD in Chinese and

"This book is useful for anyone who cares for patients with NAFLD -- specialist or generalist. It provides both a general overview as well as a detailed look at disease mechanisms, clinical assessment, diagnosis, and treatment. It comes out in a timely fashion as diseases such as diabetes, obesity, metabolic syndrome, NAFLD, and NASH are on the rise." ( Doody's , 24 January 2014)